Mutation K42R in Ribosomal Protein S12 Does Not Affect Susceptibility of Mycobacterium smegmatis 16S rRNA A-Site Mutants to 2-Deoxystreptamines
Name
Kalapala-2010-Mutation K42R in Rib.pdf
Size
404.66 KB
Format
Adobe PDF
Checksum (MD5)
8cfb127cfe2231adfe617a4a7bf0bfe5
Author(s)
Hobbie, Sven N.
Kalapala, Sarath K.
Bottger, Erik C.
Shcherbakov, Dmitry
Date Issued
April 2010
Journal
PLoS ONE
Publisher
Public Library of Science
Citation
Kalapala, Sarath K. et al. “Mutation K42R in Ribosomal Protein S12 Does Not Affect Susceptibility of Mycobacterium smegmatis 16S rRNA A-Site Mutants to 2-Deoxystreptamines.” PLoS ONE 5.8 (2010): e11960.
Version
Final published version
Abstract
Recent studies have suggested that ribosomal protein S12 modulates 16S rRNA function and susceptibility to 2-deoxystreptamine aminoglycosides. To study whether the non-restrictive K42R mutation in RpsL affects 2-deoxystreptamine susceptibility in Mycobacterium smegmatis, we studied the drug susceptibility pattern of various mutants with genetic alterations in the 16S rRNA decoding A-site in the context of wild-type and mutant protein S12. RpsL K42R substitution was found not to affect the drug resistance pattern associated with mutational alterations in 16S rRNA H44.
MIT Department
Singapore-MIT Alliance in Research and Technology (SMART)
Terms of Use
Creative Commons Attribution
Persistent DSpace Link
DOI of Published Version
https://doi.org/10.1371/journal.pone.0011960
